Search Results 11-20 of 13965 for Moderate acute malnutrition

1. A Phase 2b, Study Of Linsitinib In Subjects With Active, Moderate To Severe Thyroid Eye Disease (TED) - Mayo Clinic

   A Phase 2b, Study Of Linsitinib In Subjects With Active, Moderate To Severe Thyroid Eye Disease (TED) ... moderate-to-severe Thyroid Eye Disease (TED).

2. Alzheimer's stages: How the disease progresses - Mayo Clinic

   Mild cognitive impairment due to Alzheimer's disease. Mild dementia due to Alzheimer's disease. Moderate dementia due to Alzheimer's disease. Severe ...

3. A Study Of Vedolizumab In Children And Teenagers With Moderate To Severe Crohn's Disease (CD) - Mayo Clinic

   A Study Of Vedolizumab In Children And Teenagers With Moderate To Severe Crohn's Disease (CD) · More about research at Mayo Clinic · Mayo Clinic Footer.

4. Safety And Efficacy Trial Of RPC1063 For Moderate To Severe Ulcerative Colitis - Mayo Clinic

   The purpose of this study is to determine whether RPC1063 is effective in the treatment of Ulcerative Colitis (UC). Participation eligibility. Participant ...

5. Manpreet S. Mundi, M.D. - Mayo Clinic Faculty Profiles

   Mayo Clinic researcher Manpreet S. Mundi, M.D., studies malnutrition across its full spectrum, from severe undernutrition and muscle loss to obesity.

6. Brivekimig For The Treatment Of Moderate To Severe Hidradenitis Suppurativa - Mayo Clinic

   ... moderate to severe hidradenitis suppurativa. The purpose of this study is to assess the efficacy and safety of brivekimig in a dose-ranging study of ...

7. A Study of the Changes in Nutrition Status of Patients with Acute Myeloid Leukemia - Mayo Clinic

   The purpose of this study is to determine best practices for the assessment and timing of nutrition interventions in patients who have Acute Myeloid Leukemia ( ...

8. A Study Of Simvastatin Therapy For Moderate And Severe COPD - Mayo Clinic

   ... moderate to severe COPD who are prone to exacerbations and do not have other indications for statin treatment. Participation eligibility. Participant ...

9. Safety And Efficacy Of MMX Mesalamine/Mesalazine In Pediatric Subjects With Mild To Moderate Ulcerative Colitis - Mayo Clinic

   To assess clinical response to MMX mesalamine/mesalazine between a low and high dose in children and adolescents aged 5-17 years with mild to moderate ...

10. Dehydration - Symptoms and causes - Mayo Clinic

    Drinking more fluids usually fixes mild to moderate dehydration. But severe dehydration needs medical treatment right away. Symptoms. Thirst isn't always a ...